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Xeroderma pigmentosum (XP)/Cockayne syndrome 
(CS) complex is a combination of clinical features of 
twO rare genetic disorders in one individual. A sun-
sensitive boy (XP20BE) who had severe symptoms of 
CS, with dwarfism, microcephaly, retinal degenera-
tion, and mental impairment, had XP-type pigmen-
tation and died at 6 y with marked cachexia (weight 
14.5 Ib) without skin cancers. We evaluated his cul-
tured cells for characteristic CS or XP DNA-repair 
abnormalities. The level of ultraviolet (UV)-induced 
unscheduled DNA synthesis was less than 5% of nor-
I mal, characteristic of the excision-repair defect of 
XP. Cell fusion studies indicated that his cells were in 
, XP complementation group G. His cells were hyper-
sensitive to killing by UV, and their post-UV recovery 
of RNA synthesis was abnormally low, features of 
both CS and XP. Post-UV survival of plasmid pSP189 
• xeroderma pigm entosum (XP) is a rare autosom al 
recessive disease characterized clinically by hyper-
sensitiv ity to sunligh t, abno rmal pigmentation, 
neurologic abnormalities (in abou t 20% of the 
patients; Kraemer ef ai, 1987) , and predisposition 
to skin can cers, especially on sun-exposed areas (Kraemer, 1993; 
• C leaver and Kraemer, 1995). C ultured cells derived from XP 
pati e nts have a reduced DNA-repair capacity and are hypersensiti ve 
to lcilling by ultra vio let ]jght (UV). Cell s from patients w ith XP 
repair neither pyrimidine dimers nor no ndimer photoproducts in 
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in his cells was markedly reduced, and post-UV plas-
rnid mutation frequency was higher than with norrnal 
cells, as in both CS and XP. Sequence analysis of the 
rnutated plasmid marker gene showed norrnal fre-
quency of plasmids with multiple base substitutions, 
as in CS, and an abnorrnally increased frequency of 
G:C --J> A:T mutations, a feature ofXP. Transfection 
ofUV-treated pRSVcat with or without photoreacti-
vation revealed that his cells, like XP cells, could not 
repair either cyclobutane pyrimidine dirners or non-
dirner photoproducts. These results indicate that the 
DNA-repair features of the XP20BE (XP-G/CS) cells 
are phenotypically more like XP cells than CS cells, 
whereas clinically the CS phenotype is more prorni-
nent than XP. K ey lVol,ds: shuttle vector plasmid/ski" 
cancer/t/'allsJectiol//pl/OtoprodJ/cts. ] Invest D el'matol 107: 
647-653, 1996 
DNA afte r UV exposure (Protic-Sabljic and Kraemer, 1985, 1986). 
Cell fusion analysis has identified seven complementation groups 
(A through G) of excision-repair-deficient cells, and there is also a 
"variant" fo rm that is proficient in excision repa ir (Kraemer, 1993; 
C leaver and Kraemer, 1995) . XP group G is one of the rarest forms 
of XP, and only seven oth er patients have been reported (Chees-
brough and Killmont, 1978; Keij zer et ai, 1979; Arlett et ai, 1980; 
l chihash i et ai, 1985; Norris el ai, 1987; Jaeken e/ ai, 1989; 
Vermeulen et ai, 1993). T he human gene responsible for XP group 
G was recently identifi ed as ERCC5 (Mudgett and Macinnes, 1990; 
O'Donovan and Wood, 1993; Nouspikel and C larkson, 1994), 
whose en coded product functions as a structure-specific DNA 
endonuclease (O'Donovan and Wood , 1993). 
Cockayne syndrom e (CS) is another rare au tosomal recessive 
disease ca using acute sun sensiti vity that has characteristic progres-
sive neuro logic symptom s in addition to short stature, mkroceph-
aly, pigm entary retina l degeneration , progress ive sensorineural 
hearing loss, and calcifi cation of basal gang li a. Although CS 
patients may ha ve severe sunbulTI on minimal exposure, t1ley do 
not deve lop the characteristic pigmental), abnorma lities and skin 
ca ncers seen in X P (Cantani el ai , 1987; Nance and Berry, 1992; 
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Kraemer, 1993; Cleaver and Kraemer, 1995). Cu ltured cells 6:om 
CS patients have XP-type hypersensitivity to killing by UV (An-
drews et ai, 1978; MarshaU et ai , 1980). Unlike XP, however, the 
level of DNA repair in CS cells measured by UV-induced unsched-
uled DNA synthesis (UDS) is normal. CS cells have defective repair 
of actively transcribing genes, whereas repair of total genomic 
DNA is normal (Venema ct ai , 1990). There are two CS comple-
mentation groups (CS-A and CS-B) (Lehmann, 1982; Stefanini et 
ai, 1996), and the corresponding genes have been cloned (Troelstra 
et ai, 1992; Henning ef ai, 1995) . Recently, Barrett el a/ (1991) and 
Parris and Kraemer (1993) used sh uttle vector plasm.ids to demon-
strate that CS cells are deficient in repa.ir of cyclobutane dimers but 
are proficient in repair of nondimer photoproducts. 
XP/CS complex has been proposed as a clinical entity with 
features of the two rare genetic diseases , XP and CS (Robbins el ai, 
1974; Robbins, 1988). Patients show the neurologic abnormalities 
of CS plus the sk.in abnormalities of XP, including sk.in cancers. 
Cells from patients with the XP/CS complex are hypersensitive to 
k.illing by UV, but unlike the usual CS ce Li s, have reduced 
UV-induced UDS (Kraemer, 1993; C leaver and Kraemer, 1995). 
This study provides information about XP20BE, the eighth patient 
with the XP/CS complex and the th.ird patient with this complex in 
XP complementation group G. The DNA-repair characteristics of 
the XP20BE (XP-G/CS) cells are more like XP than CS, whereas 
clinically the CS phenotype is more prominent than that of XP. 
MATEIUAL5 AND METHODS 
Cells Lymphoblastoid cell li ncs were established by Epstcin-Barr virus 
transformation of peripheral blood lymphocytes from thc ncw patient with 
XP/CS (XP20BE = AG08802), a paticnt with XP group A (Xp12BE = 
GM02250) (Robbins ef ai, 1974), and a normal individual (GM606) . All of 
the cells were transformed at the Institute of Medical R csearch (Camden, 
NJ) and were culturcd in RPMI 1640 medium (GLBCO BRL, Bethesda, 
MD), supplemented with 15'X, fctal bovine serum (S&5 Media , Rockville, 
MD) and 2 mM L-glutaminc (Gibco I3RL) , at 37°C in a 5'X, CO2 
atmosphere, as described previously (Moriwaki et ai, 1994). 
Primary fibroblast cultures were estab lishcp at the Institute of Medica l 
Research from skin biopsy specimens of the new patient with XP/CS 
(XP20BE = AG08803), his mother (AG8805), and his father (AG8807); 
patients with XP group A (XP12BE = GM05509) (Robbins et ai, 1974), 
group C (XP21BE = GM09943), and group D (XPLA-BE = KR5959) 
(Kracmer et ai, 1989); and four normal subjects (GM1652, GM2987, 
GM3377, and GM3651) . Additiona l fibrob last stra ins used were Xpl1 PV 
and XP25RO (XP group A), XPllBE = Xp/CS-1 (Xl' gro up 13) (Robbins 
ef ai, 1974), Xp13pV and Xp21RO (Xl' group C), Xl'3NE and XP/CS-2 = 
GM03248 (XP group D), Xp2RO = GM02415 (Xl' group E), Xp2YO = 
GM04313 (XP group F), XP2BI = GM03021 (Xl' group G), CS4BR and 
CSIpV (CS group B) (Stcfanin i cf ai, 1996), and C5RO, C3PV, and lBR 
(normals). Ccll s wcre main tained in Dulbccco's modifi ed minimum essen-
tial medium (GIBCO BRL) with 15'1u fetal bovine serum (S&S Media) and 
2 mM L-glutamine (GLBCO BRL). 
Post-UV Cell Survival, Measurement ofUV-Induced UDS, Genetic 
Complementation Testing, and RNA Synthesis Inhibition UV 
treatment was performed with a germicidal lamp, and cell survival was 
measured in nonproliferating fibroblasts as described previously (Stefanini ef 
ai, 1992, 1993). Autoradiographic measurement of post-UV UDS and 
complcmentation group determination were performed as described previ-
ously (Vermeulen ef ai , 1991; Stef.lnini ef ai, 1992). BrieRy, primary 
fibrob lasts were was hed w ith phosphate-buffered sa line before UV irradia-
tion, followed by incubation in a medium cont"ining 10 !LCi m ethyl 
[.1HJthymidine per ml for 3 h. Mter labeling, the cells were fixed with Bouin 
so lu tion. The slides were dipped in nuclear track cmulsion for autor"diog-
raphy. The number of grains per intcrphase nucleus was scored for 100 
nuclei in each sanlplc. 
Genetic complementation tests were performed by assessment of UV-
induced UDS (10 - 30 J/m 2 ) of the p<ltient's fibroblasts fused with represen-
tative Xl' strains of complementation groups A, 13, C, D, E, F, and G 
(Vermeulen cf ai , 1991) . E"ch cell line to be fused was treated with a 
different size of microscopic beads, which were incorporated into the 
cytoplasm as a marker. Forty- eight hours afte r fu sion by polyethylene glyco l 
or by {3-propiolactone-inactivated Sendai virus, post-UV UDS was mea-
sured. The nlllnber of grains in 10-60 nuclei of heterok"ryon cells 
containing bo th sizes of microscopic beads was scored . 
Post-UV inhibi tion of RNA synthesis was performed as described 
THE JOUJl..NAL OF INVESTIGATIVE DER.MATOLOGY 
previously (Lehmann cf ai, 1993). Fibroblasts were exposed to UV , and 
[' HJuridine incorporation was measured after 24 h incubation. 
Plasmid UV Treatment, Transfection, Chloramphenicol Acetyl 
Transferase (CAT), and Mutation Assay Assessment of post-UV 
DNA repair and mutagenesis by plasmid host ce ll reactivation was per-
formed as described previously (Protic-Sabljic and Kraemer, 1985; Mori-
waki cf ai , 1994). The pRSVcat and pSP189 plasm ids were diluted to 31 I-Lg 
per ml in sterile distill ed watcr and werc irradi"ted on ice using a germicidal 
lamp at a rate of 1.5 J/m 2 /s, measured w ith an In ternational Light 
(Newburyport, MA) IL770A Rcsl:arch Radiometer. Transfection was per-
formed by usc of diethylaminoethyl dextran (Pharmacia Fine Chemicals, 
Uppsa la , Sweden). 
For the mutagenesis assay, 3 X 107 Iymphoblastoid cells were transfected 
with UV-treated o r untreated pSP1 89 . At the same time, nonirradiated 
pZ189K was co-transfected as "n internal standard. Two days after the 
transfection, replicated plasmids were recovered from the human cells by 
alka line lysis and used to transform an indicator strain of Escherichia coli by 
e lectroporation. The ratio of the total number of ampicillin-resistant 
co lonies to the tota l number of kanamycin-res istant colonies reRects plasmid 
survival. The proportion of w hi te or light blue co lonies (representing 
inactivating mutations in the s/lp F gene) to the total number of colonies is 
a measure of the mutation frcquency. Mutant white or light blue colonies 
were subjected to sequence analysis using the SequiTherm Cycle Sequenc-
ing Kit (Epicenter Techno logies , Madison, WI) . 
For the CAT assay , 3 X 107 lymphob lasto id ce lls were transfected with 
UV-treated or untreated pRSVcat, and CAT assays were perfornled 
according to the scinti llation cockta il extraction procedure (Gozlikara et ai, 
1994). Enzyme activity was determined aftcr 1-6 h incubation and e.-,,-
pressed as pmollmin/ mg prote in . Protein detcrmination was perfonned 
with thc Bio-Rad protein assay kit (Bio-Rad Laboratories, H ercules, CAl. 
The E. coli enzyme photolyase, a gift [rom A. Sancar (University of North 
Carolina), was used for dimer remov,,1 from UV-irradiated pRSVcat 
plasmid. UV-treated and untreated pRSVcat was mixed with photolyase 
and treated with 405 nm monochromatic visible light for 1 h , as described 
prev iously (Protic-Sabljic and Kraemer, 1985, 1986; Panis and Kraemer, 
1993). The efriciency of dimer removal from pRSVcac by photoreactivation 
was detcrmined by digestion of the DNA with T4 endonuclease V (a gift 
from S. Lloyd, Ga lveston , TX) , which cleaves the plasmid at sites contain-
ing dimers. Plasmid DNA with or without photoreactivation was analyzed I 
by agarose gel electrophoresis , and the proportion of form I (supercoiled 
monomer plasmid) was detcrmined by a laser densitometer (Molecular 
Dynamics, Sunnyvale, CAl. W e found that T4 endonuclease V digestion of 
250 J/m 2 UV-treated pSR.Vcat plus photoreactivation resulted in the 
retention of 88')1,) of form I molecu les, compared with 9% of form I 
molecules in the T4 endonuclease V-digested , UV-treated plasmid without 
photoreactivation. T hese resu lts indicate that the photoly"se treatment 
removed about 95% of the cyclobutane pYlimidine dimers , calculated as 
described (Protic-Sabljic and Kraemer, 1985, 1986) . 
Statistical Analysis Statistical comparisons of differences between spe-
cific mutations were performed by Fisher exact tcst, and l-tailed p values 
are shown. For the studies of cell surviva l, plasmid survival, and plasmid 
mutation fI'cquency, means were compared with Student t test and curves 
were plotted using the Sl ideWritc Plus computer program (Advanced 
Graphics, Carlsbad, CAl. 
RESULTS 
Case Report The 6-y-old boy (XP20BE) was referred to the 
National Institutes of Health at age 18 mo because of marked sun 
sensitivity and developmental delay. He was born in December 
1984 after a normal pregnancy, weighed 6 lb 10 OZ, and had a 
normal Apgar score. H.is parents were clinically normal and unre-
lated. T hey reported that in the spring, minimal exposure of the 
patient to sunlight would be followed on the next day by progres-
sive redness and swelling, especially of his face . The reaction 
became severe and persisted for about 1 wk. He had about oioe 
separate episodes of severe sun reaction . The parents began pro-
tecting him with sunscreens and long- sleeved clothes at all time . 
At age 5 mo, he weighed 16 Ib and could roll over. H.is motor 
sk.i lls then ccased to develop. At 1 y of age, he had microcephaly 
and failure to thrive and was diagnosed as having CS. 
He rcached his maximum weight of 19 Ib at age 18 mo. His skin 
showed multiple hyperpigmented 1-2-mm macules of varying 
color on sun-exposed surfaces, including his lips. These freckles 
were interspersed with hypopigmented macules and were associ-
ated with mild atrophy and telangiectasia (Fi_g 1, /rji). There were 
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no actinic keratoses or skin cancers. He was diagnosed as ha ving the 
clinical features ofXP. Skin biopsies and blood cultures were done 
for DNA-repair tests. 
Neurologic examination showed microcephaly w ith markedly 
delayed motor and language ski lls. He had pigmentary degenera-
tion of the retina and moderate to severe sensorineural hearing loss . ~ Magnetic resonance imaging showed cerebell ar hypoplasia and 
enlarged ventricles . Electrophysiologic studies showed slowed con-
duction and diffuse denervation. 
He experienced progressive cachexia, weighing only 14.5 Ib at 
age 6 y (Fig 1, right). He died of pneumonia in February 1991. 
Autopsy of the nervous system showed demyelination of the white 
matter, calcification of the brain, cerebellar degeneration, and a 
, demyelinating peripheral neuropathy. These autopsy findings are 
typical of CS. A detailed report will be presented elsewhere. 
Reduced Post-UV Survival Post-UV survival of nonprolifer-
acing XP20BE fibroblasts was compared with that of fibroblasts 
from patients in XP complementation groups A, C, and D; from 
one CS patient; and from one normal donor (Fig 2) . T he post-UV 
survival of the XP20BE cells was extremely low and simil ar to that 
from cells in XP complementation group A. 
Reduced UDS and Complementation Group G Assignment 
The le vel of post-UV UDS in XP20BE cells was compared with 
that of cells from two normal subjects, his parents, and fi'om 
patients in XP complementation groups A, B, and C (Table I). The 
level ofUV-induced UDS in the XP20BE cells was less than 5% of 
~ normal, characteristic of a severe form of the nucleotide excision-
repair defect of XP. T he post-UV UDS of his parents' cells was 
• normal, as is usually seen in obligate XP heterozygotes. 
XP20BE fibroblasts were fused pairwise with representative 
fibro blasts from XP groups A, C, D, E, F, and G in Pavia (Fig 3A) 
and with fibroblasts from XP groups A, B, C, and G in Rotterdam 
(Fig 3B) . Binuclear heterokaryons showed normal or near-normal 
levels of post-UV UDS when the XP20BE cells were fused with 
cells from XP groups A, B, C, D , E, and F. In contrast, binuclear 
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Figure 1. Paticnt XP20BE, with fea-
tures of CS and XP. Leji, Age .1 8 mo, 
showing interspersed areas of XP-like in-
creased and decreased pigmentation on the 
check. Rigllf, Age 6 y, showing typica l CS 
cache";,,, deep-set eyes, loss of subcutaneous 
tissue. and XP-like pigmentation of the face 
and ann. 
heterokaryons of XP20BE cells resulting from fusion with the 
XP-G cells showed no increase in UDS, indicating assignment of 
the XP20BE cells to XP compl ementation group G. 
Reduced Post-UV RNA Synthesis Post-UV inhibition of 
RNA synthesis was assessed in the XP20BE cells in comparison 
with cells £i'om his parents, fi'om XP-C and XP-D patients , from a 
patient with CS, and from two normal donors (Fig 4). CS cells 
typically show dose-related delayed recovery of RNA synthesis 
(Mayne and Lehmann, 1982; Lehmann et ai , 1993). There was a 
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Figure 2. Rcduced post-UV survival of XP20BE cells . Nonprolifer-
ating fibroblasts from the patient XP20BE (.); patients in XP complemen-
tation gro ups A (XP11PV, ~) , C (XP13llE, _) , and 0 (XP3NE, + ); 
XPLA-BE (e); CS complementation group B (CSl PV, .); and normal 
subject (C3PV, 6 ) were exposed to different doses of UV, and cell surviva l 
was determined (sec Materials alld Me/hods). Data poillts for XP3NE arc 
displaced for better visibility. 
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Table I. Markedly Reduced Post-UV Unscheduled DNA 
Synthesis in XP20BE Fibroblasts 
Cells Grains/Nucleus" 
Normal (GM1652) 
Normal (C5RO) 
Mother (AG8805) 
Father (AG8807) 
XP20BE 
XP-A (XP25RO) 
XP-B (XP11BE) 
XP-C (XP21BE) 
" Mean ± SEM ; UV dose = 16 ]1m2 
56 ± 2 
57 ± 2 
58 ± 1 
55 ± 2 
1 ± 0.3 
1 ± 0.3 
3 ± 0.5 
16 ± 1 
Normal 
100% 
102% 
105'Yo 
98% 
1.7% 
1.7% 
5% 
29% 
greater reduction in post- UV RNA synthesis in cells fi'om the 
XP-D patient. The XP-C cell line showed normal recovery of 
post-UV RNA synthesis. The XP20BE cells showed reduced 
post-UV RNA synthesis to a similar extent as in the XP-D cells. 
The cells from the clinically normal obligate heterozygotes showed 
normal post-UV inhibition of RNA synthesis. 
Increased Post- UV Plasmid Mutagenesis UV -treated 
pSP189 passed through normal , XP20BE, and XP-A Iymphoblas-
toid cells showed a decrease in the relative number of ampicillin-
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Figure 3. Complementation testing of XP20BE cells demonstrat-
ing assignment to XP complementation group G by cell fusion . 
Post-UV UDS was determined in binuclear homokaryons ofXP2013E (closed 
bars) , binuclear homokaryons of the other cell strain (opell bars), and 
heterokaryons (s"aded bars) of XP20BE cells fused to representative cells of 
different XP complementation groups. The bars indicate the percentage 
UDS for the indicated cell strain compared with that of the concurrent 
norma l. The alTOII! indicates lack of complementation ofXP20BE cells when 
fused with the XP-G (XP213I) cell line. (A) Fusions of XP20BE cells with 
XP-A, -C, -0, -E. -F, and -G cells performed in Pavia. The UDS of the 
normal control was 45 grains/nucleus for fusions with XP-A (XP11 PV), 
xp-c (XP13PV). and XP-D (XP3NE); 62 grains/nucleus for fusions with 
XP-D (XPCS2) and XP-G (XP2B1); and 85 grains/nucleus for fusions with 
XP-E (XP2RO) and XP- F (XP2YO). (B) Fusions of XP20J3E cells with 
XP-A, -13, -C, and -G cells performed in Rotterdam. The UDS of the 
normal control was 41 grains/nucleus for fusions with XP-A (XP25RO) , 
XP-C (XP21 RO and XP21 BE), and XP-G (XP2BI); and 98 grains/nucleus 
for fus ions with XP-13 (XP11J3E). Error liars, mean ± SEM. 
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Figure 4. Abnormal post-UV inhibition of RNA synthesis in 
XP20BE cells. Fibroblasts were treated with the indicated doses ofUV and 
incubated for 24 h, and then the I~A synthesis rate was determined. 
Results arc shown for cells from the patient XP2013E (.), two nomla! 
donors (GM1652, 6 ; and 1BR, 0 ), the parents of the XP2013E patienr 
(AG8805, \7 ; and AG8807, 0 ), one patient with CS (CS4BR, A) , and 
patients in XP complementation groups C (XP21BE, _) and D (XPLA-BE . 
• ). The XP2013E fibrob lasts showed marked post-UV inhjbition of RNA 
synthesis similar to that of the XP-D patient. 
resistant colonies in a dose-dependent manner (Fig SA). Survival of 
UV-treated pSP189 recovered from XP20BE cells was much lower 
than that from normal cell s. The reduction of post-UV plasmid 
survival in XP20BE cells was similar to that in the XP-A cells. 
Post-UV pSP189 mutation frequency was measured in the 
XP20BE, normal, and XP-A lymphoblastoid cell lines (Fig SB) . 
UV treatment of the plasmid enhanced the fi'equency of mutant 
colonies recovered, in a dose-dependent manner, with all of the 
ceUs. The mutation frequency of the UV-trea ted plasmid recovered 
from the XP20BE cells was significantly greater than norma l at 25 0 
]1m 2 and 500 ]1m2 . The XP-A cells showed greater plasmid 
hypermutability than the XP20BE cells. The fi'equency of sponta-
neous mutations in pSP189 was similar in XP20BE, normal, and 
XP-A cells (data not shown). 
DNA sequence analysis w as performed on 69 independem 
post-UV mutant plasmids recovered from the normal cells and on 
80 post-UV mutant plasmids recovered fi'om the XP20BE cells. 
The classes of mutations in the slIpF marker gene in UV-treated 
pSP189 are shown in Table II. With both cell lines, most mutant 
p lasm ids contained point m utations (83% and 79%, respectively), 
with very few frameshift mutations (one large deletion and one 
single-base insertion along with a base- substitution mutation with 
the normal line) . Plasmids with tandem mutations (two base 
substitutions zero to two bases apart or th ree adjacent base substi-
tutions), a feature of UV mutagenesis, w ere recovered fi'om 9% of 
the mutants with both cell lines. Multiple base-substitution muta-
tions (two substitutions three or more bases apart or th ree or more 
nonadjacent base substitutions in the approximately 150- bp m arker 
gene) were found in p lasmids recovered from both cell lines. As 
with CS cells (Parris and Kraemcr, 1993) , there were no significant 
difiercnces in the frequencies of classcs of mutations with both cell 
lines. 
Analysis of the types of single and tandem base- substitution 
mutations showed a significant increase in G:C ---7 A:T transition 
mutations in the plasmids recovered fi'om the XP20BE cells (Table 
III). Sim ilar results were seen at all UV doses. This p redominance I 
ofG:C ---7 A:T transitions in post-UV plasmid mutagencsis is typical 
of XP cells (Cleaver and Kracmer, 1995) but is not seen with C 
cells (Muriel et ai , 1991; Parris and Kraemer, 1993) . 
Reduced Repair of All UV Photoproducts UV- treated 
pRSVcat plasmid with or without photoreac tivation was used to 
measure the DNA-repair ability of normal, XP20BE, and XP-A 
Iymphoblastoid cells (Fig 6) . This assay reflects the ability of the 
cells to repair the damaged plasmid DNA by assessing the recovery 
of transcriptional activity, measured indi rectly as enzyme activity of 
~ 
VOL. 107. NO.4 OCT013ER 19% 
~ 100 
-I 100 
---
A c 
----- ~ ~ 
~ ~~1~ -"1:-- ___ II 
::t ~t.v ---
--a-IR 10 '~ II 
fiI 
IR ,. 
C 
-I 
Go ~ UI j; 
:5 0.1 UI 
a: 0 100 100 SOO 400 800 
• 
~ B 
II 
• >-() • Z 4 / • UI 
::t / is''I-~ a • UI .:r IE a {/I'/' • z I 0 II II t= / NCJf"M"L ------c 
... 
, 11 
---
---
::t 
---
11 
=- 0 
0 100 100 SOO 400 800 
UV DOSE TO PLASMID (J.m-I ) 
Figure 5. Reduced survival and increased mutation frequency of 
uv - treated plasmid replicated in XP20BE, XP-A, and normal 
• lymphoblastoid cells. pSP I89 was treated w ith 0-500 Jlm ~ UV and 
transfected along w ith un treated in terna l standard plasmid (pZ I 89 K) b)' 
diethylaminoc th),1 dextran in to the X P2013 E (.). XP-A (XPI 213 E, _) , and 
no['ma1 donor (GM606. 6 ) I),mphoblastoid ce lls. Afte r 2 d . the replicated 
plasm ids \vcrc harvested :llld lI sed to tra nsfo rm ind icator b<1 c tc ria to 
resist3.n.ce to :lITIpici llill o r ka ll an lyc in. Each point represe ll ts th e rl1 Ca ll of 
twO to three il1dependent dctcnnillatio l1 s ill se para te experiments. (AJ 
Norma lized re lative plasmid sUJ'viv,1i plo tted as a fun ction ofUV dose to the 
plasmid. (8) T he bacte rial co lonies obtained were ana l),zed for plasmids 
with w-i ld-type slIpF (dark blue co lo nies) or mu tated slIpF gene (white or 
) light blue colon ies). T he mutation frequ encies of the plasmids arc plotted as 
a function of UV dose to the plasmid . 
the trans fec ted gcn e . W h e n thc t ransfecting plasmid was irradi ated 
wi th 250 Jlm 2 and n ot photoreac ti vated, the CAT ac t ivity of th e 
XP20BE and XP-A lin es was lower than th at of th e no rma l lin e 
(p < 0 .01). T his redu ced post-UV CAT activ ity is typica l of both 
XP and CS cell s (Barre tt 1'/ nl, 1991 ; Parri s and Krae m e r , 1993). 
Reversa l of cyclobutane dimers b y photoreactivati n g the plasmid 
trea ted with 250 J / m2 be fore trall sfection resulted in increase d 
CAT activ ity in all lines. T he level of CAT ;,cciv ity aftcr 250 Jlm 2 
pl us photoreactivation in th c XP20BE o r t hc XP- A cell s, h owever, 
was significantl y lower t h all that of the no rma l ce ll s (p < 10 -" ). 
Table II. Normal Classes of Mutations in UV-Treated 
pSP189 Replicated in XP20BE Lymphoblastoid Cells 
Independent plasmids seq uenced 
Point rnut~l ti o ll S 
Single 
Tandem 
Mu ltiple 
Dele tions 
• UV d ose to plas lIlid- 1 000 or 500 JlII'O. 
• UV dose co plaslIlid-250 or 500 JlIIl ' . 
N U1I1ber of Plasm ids W ith 
Base C hanges (,X,) 
Normal (GM606)" 
69 (100%) 
57 (83%) 
6 (9%) 
5 (7'1u) 
1 (1%) 
XP2013E" 
80 (100%) 
63 (79%) 
7 (9%) 
10 ( 13%) 
o 
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Table III. High Frequency of Transition Mutations in 
UV-Trcated pSP189 Replicated in XP20BE 
Lymphoblastoid Cells 
Number of Base C hanges ('Yo) 
Base C hange 
Trrl11 sitio ns 
G:C -> A:T 
A:T -> G:C 
Tr:tnsvcrsions 
G :C -> T:A 
G:C -> C:G 
A:T -> T:A 
A:T -> C:G 
Tota l 
Normal 
(GM606)" 
26 (38%) 
21 (30%) 
5 (7%) 
-13 (62%) 
14 (20%) 
10 (15%) 
10 (15%) 
9 (13%) 
69 (100%) 
., UV dose to pla slIlid-1 000 or 500 JlIIl ' . 
,. UV dose to pIaslllid-250 or 500 J / m 2 
' p < 0.000 1. 
" P < 0.02. 
XP20BE 
(XP- G/ CS)" 
59 (76%)' 
55 (71 %)' 
4 (5%) 
19 (2-1 %)' 
11 (14%) 
2 (3%)" 
4 (5%) 
2 (3%)" 
78 (100%) 
T his findin g is typica l of XP cell s, w hic h are una bl e to re pair 
nondimer photoproducts, but is diffe re n t fro l11 CS cell s, which have 
n o rmal CAT expressio n of UV -treated plasmids th at a re treated b y 
photoreac tivation (Barrett el nl, 1991 ; Parris and Kraemer, 1993). 
DISCUSSION 
XI' and CS are c lin icall y distinct di sorders that h ave in commo n sun 
sen siti v ity, microcepha ly , d ea fi1ess, an d progress ive neuro logic 
degen e ration (Kraem e r , 1993; C leaver and Kraemer, 1995). Ap-
proximately 20'!!0 of XP patients have associated n e urologic abnor-
m a lities of va rying severity (Kraeme r CI nl, 1987). T he m ost severe 
form has been ca ll ed the De San ctis-Cacchi o ll e syndro m e . T hese 
patie n ts can be di sting ui she d fi'om th ose w ith CS b y absence of 
retin a l degen e ration, decreased to absent d eep tendon re flexes , 
primary n euron a l degen e ratio n, and a bsence of calcification of the 
basa l gan g li a and other brain stru c tures . Pa t ie nts w ith CS, in 
con trast, do not sh ow XP-type skin freck ling o r skin can cer but do 
have in c reased o r n o rmal deep tendon re flexe s. sign s of primary 
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Figure 6. Reduced repair of cyc10butane dimer and nondimcr 
photoproducts in XP20BE cells. Plasmid pRSVcat was o'eated with 250 
J/ m2 UV alone (_) o r with UV fo llowed b)' photorcactivation (PR) (~) to 
remove c),c1 obutane dimcr photoproducts. and then transfected in to 
XP20B E. X P-A . and norlll al 1)' lllphoblasto id cell s. Each bar represents the 
mean ::': SEM of trip lica te dcterminations of CAT activity fo r each ce lll;ne. 
T he mean specifi c CAT activit), w ith the contro l un irradiated plasmid was 
0.6 Plllol/l11g/nlin with the normal (GM606) linc . 2 pl1lo-l/mg/ min with the 
X P20 UE line. and 7 pl1lo l/ mg/min with the XP-A (XPI2T3E) line. The 
post-U V CAT acti vit), with the XP20BE and XP-A cell s was signifi cantly 
lower than that of the normal line with UV (p < 0.01) and with UV plus 
photoreactivation (p < 10- "). 
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demyelination (tigroid leukodystrophy), and often, calcification of 
the brain (Cantani e/ ai, 1987; Nance and Berry, 1992; Kraemer, 
1993; Cleaver and Kraemer, 1995). The neurologic abnormalities 
of XP result from a primary neuronal degeneration (Robbins e/ ai, 
1974, 1991); those of CS result from abnormal myelination (Can-
ta ni et ai, 1987; Nance and Berry, 1992). T he term "XP neurologic 
disease" (Robbins e/ ai, 1991) has been applied to the neurologic 
signs and symptoms described in XP-A patients and in certain 
XP-D patients (Robbins e/ ai, 1974, 1991) . The term "XP/CS 
complex" has been proposed (Robbins e/ ai, 1974; Robbins, 1988) 
for patients who have pigmentary cutaneous features of XP to-
gether w ith one 0 1' more of the characteristic features of CS (e.g., 
primary demyelination, pigmentary retinal degeneration, calcifica-
tion of the basal ganglia) . 
The patient reported here, XP20BE, had severe signs of CS 
including acute su n sensitivity, retina l degeneration, cachectic 
dwarfisln, dearness, mental impairment, microcephaly, demyelina-
tion, and calcification of the brain . In addition , he showed the XP 
type of pigmentation on his sun-exposed skin, whjch led to the 
clinical diagnosis ofXP even though there was no evidence of skin 
cancer. C linica lly, CS was predominant, bu t he also had pigmentary 
changes of XP. He therefore fu lfills the clinical diagnosis of the 
XP/CS complex . 
The XP20BE cells derived from o ur patient showed DNA-repair 
abnormalities common to XP and CS, including cellular and 
plasmid UV h ypersensitivity. T he XP20BE cells had very low 
UV-indl.lced UDS (Table I), a feature ofXP, and were found to be 
in the rare XP group G by genetic complementation study (Fig 
3A,B). T he XP20BE cells showed delayed post-UV recovery of 
RNA synthesis (Fig 4), an abnorma li ty seen in CS ceIJs and also in 
XP-D (Fig 4), XP-A (XP4LO), and XP-G (XP2BI) ce IJs (Mayne 
and Lehmann, 1982); in the two other XP-G ICS cell lines studied 
Oaeken e/ ai, 1.989); and in XP-B/CS (Vermeulen e/ ai, 1994a). We 
found a significantly eleva ted frequency of transition mutations , 
especia lly G:C ~ A:T base changes (Table III), in UV-treated 
plasmids recovered fi:om XP20BE cells compared with the normal 
line, a feature seen in XP cells (Cleaver an,d Kraemer, 199 5) but not 
in CS. cell s (Muriel e/ ai, 1991; Parris and Kraemer, 1993). The 
fi:cquency of UV-treated plasmids with multiple base substitutions 
recovered from the XP20BE cells was normal, however (Table II), 
which is a feature of CS cells (Parris and Kraemer, 1993). T he 
activ ity of CAT cnzyme usingUV -irradiated pRSV cat was very 
low in XP20BE cells and in XP-A cells compared with a normal lin e 
(Fig 6). A similar abnormality was described for the other two 
XP-GICS cell lines Oaeken e/ ai, 1989). Thjs finding indicates the 
presence of a DNA-repair deficiency in actively transcribing genes 
in XP20BE cell s, as in XP and CS cells (Barrett ct ai, 1991). The low 
post-UV UDS implies that the XP20BE cells also have a DNA-
repair deficiency in the entire genome. After photoreactivation of 
UV-irradiated pRSVcat, the CAT activity in the XP20BE line was 
stil l very low, as in the XP-A line, and did not in crease to the level 
of a normal lin e (Fig 6). T lus result indicates that the XP20BE cells 
are defective in the repair of both cyclobutane dimers and nondimer 
photoproducts, a characteristic of XP cells that distinguishes them 
from CS ce ll s, w hich are able to repair nondimer photoproducts 
(Barrett e/ ai, 1.991; Parris and Kraemer, 1993). 
Cell fusion studies indicated that XP20BE, who is the eighth 
XP/CS patient assigned to a complementation group, is in XP 
complementation group G (Fig 3A,B) and represents the third 
XP-GICS patient (Table IV). The rare XP-G complementation 
group so far has been diagnosed in only seven other patients 
(Cheesbrougb and Kinmont, 1978; Keijzer e/ ai, 1979; Arlett et ai, 
1980; lc hih ashj et ai, 1985; Norris e/ ai, 1987; J aeken et aI, 1989; 
Vermeulen e/ ai, 1993). C linica l symptoms of XP were variable in 
these seven XP-G patients, including mild or severe disease and 
w ith different rates of post-UV UDS «5% to 25% of normal). 
The seven other XP/CS patients described in the lite rature who 
have been assigned to complementation groups fa U into three 
different XP complementation groups (Table IV): group B, three 
patients (Robbins e/ ai, 1974; Scott e/ ai, 1993; Vermeulen e/ ai, 
1994a); group 0, two patients (Moshell e/ ai, 1983; Vermeulen e/ ai, 
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Table IV. Varied Clinical and Laboratory Features of 
Eight Patients With the XP/CS Complex" 
Complcmcntation Skin Post-UV 
Patient Group Agel Sex Cancer UDS 
XP11BE/' 13 33 y' /F Ycs (18 y)" 4% 
XPCS1I3A,j" 13 38 y/M No 5% 
XPCS2BA,:r il 4 1 y/M No 5% 
XPCS2-' D 13 y'/ M Yes (2 y)" 30% 
XP8Bll' D 2.5 { 1M No 30% 
XPCS1LV/' G 6.5 y'/ F No 5% 
XPCS2LV" G 1.7 { 1M No 5% 
XP20BE i G 6. 1 {1 M No 1% 
" All patients hild slin sensitivity . neurologic almofm:d itics. ,HId retinopathy. 
" R.obbins e ( (11.1974. 
r Age at death. 
,/ Age at first skin can cer. 
r Broth e rs. 
f Scott ('t nl. "1993; Vermeulen ('I fll , 1994;1. 
,I! Moshell el ai , 1983; Vcnncu lcn (' f til. 199"1; Broughton I!t fll, 1995. 
/. Jackcl1 cf nl. 1989; Vermeulen ct 0/. 1993. 
( T his report. 
1991; Broughton e/ ai, 1995); and gro up G, two patients Oaeken ei 
ai, 1989; Vermeulen e/ ai, 1993) . T he clinical presentations of these 
patients were variable, with predominance ofXP with skin cancers 
in some patients and predominance of CS features of cachexia in 
others. All three XP-B patients that have been reported had the 
XP/CS complex. They lived beyond 30 y of age, but only olle 
developed skin cancer (Table IV) . Two patients with the XP-B 
defect had trichothiodystrophy, a disorder with sun sensitivi ty , 
brittle sulfur-deficient hair , and menta l retardation without XP Or 
skin cancer (Vermeulen et ai, 1994b) . XP complementation group 
o shows marked clinical heterogencity . More than 30 patients with 
the XP-D defect have been described (Cleaver and Kraemer, 
1995). Most had clinical XP, and m any had XP-type progressive 
neurologic degeneration. Two XP-D patients had the XP / CS 
complex and one had skin cancer; both died before age 15. More 
than a dozen patients with the XP-D cellular defect have been 
reported as ha ving trichothjodystrophy without clinjcal features of 
XP or skin cancer (Stefanini c/ ai, 1992, 1993). Like XP20BE, the 
other two XP-GICS patients had severe CS and died in early 
childhood Oaeken e/ ai, 1989; Vermeulen e/ ai, 1993) (Table IV). 
The genes responsible for XP-B (Weeda et ai, 1990), XP-D 
(Weber c/ ai, 1990; Flejter et ai, 1992), and XP-G (Mudgett and 
MacInnes, 1990; O'Donovan and Wood, 1993) have been cloned 
and located o n different chromosomes (2, 19, and 13, respectively). 
There is evidence that the gene products of XP-B, XP-D, and 
XP-G interact with several other proteins to form a DNA-repair 
complex (Aboussekhra e/ ai, 1995; Bootsma et ai, 1995; Mu et al 
1995). The XP-B and XP-D gene products are thought to function 
as helicases, which unwind DNA, and the XP-G product is a UV 
endonuclease that incises the DNA 3 ' to the photoproduct 
(O'Donovan and Wood, 1993). T he XP-B and XP-D gene prod-
ucts are also part of the basal transcription factor TFIIH (Bootsma 
e/ ai, 1995). It has been postu lated that these genes playa dual role, 
acting in eith er DNA repair or transcription, and that patients with 
XP represent defects primarily in the repair function, whereas those 
with symptoms of CS represent "transcription defective disorders" 
(B ootsma e/ ai, 1995). Thus, patients with the XP/CS complex 
would hypothetically have defects in a gene involving both tran-
scription and repair activities. T his postulate might explain the 
existence of patients with XP/CS complex in XP complementation 
groups Band 0, but to date no transcription activity has been 
reported in the XP-G genc product. Analysis of the mutations in the 
XP-G gene (Nouspikel and C larkson , 1994) has been published for 
one XP-G patient, XP125LO (Norris c/ ai, 1987), who at age 12 y 
had mild XP with no skin cancers or neurologic abnormalities. 
XP125LO had a paternally derived nonsense mutation and a 
maternally derived missense mutation. Analys is of the XP-G gene 
in XP20BE may provide insights into the origin of the XP-GICS 
VOL. 107. NO.4 OCT O I3ER 1996 
complex and explain our findings that the XP20BE cells are morc 
Like XP cells than CS cell s in DNA-rep;l ir tests, whereas clinically 
the CS phenotype is more promincnt than the XP phenotype. 
This lVork lIIas slIpported ill parI b)' TeI",IIolI G ralll E. 19 7 10 M.S. alld E.G. , alld 
G ranl GH10'<-CT94-0443 10 M .S., A.R.L., ntld J.H. I,V,' I"isll 10 IIInllk Dr. 
DOl/aid J. l>Vigla, ",11o lII ade Ill e origillal diag ll osis ,!F Cocka),lI e s)'lId/'OIIIC; Dr. Cra(~ 
Dise, 11,110 pCljimlled III " alllops)'; Dr. Dellllis I'V. Dicksoll , 11,1", peljil1'111 cd Illc 
nellropaillologic sllld),; Dr. Penrl S. Rosellhalllll, 111110 pClj;I1'111cd til e opili/wllllic 
path olog), exalllillalioll; l\tTrs. I. /Inti de Veldc, ",110 (Iss islcd ill eell)ilsioll cxpcrilllellts 
il1 Rotterdam,' a"d lite parclllS of 'he patiellt, who "'ere e;>.'trcllldy jt)rt!Jc01/1i11g "ltd 
coopera lil1c ""der d{Uiclllf CirCl/lIISlnllees. 
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